Mesoblast Limited to Post FY2018 Earnings of ($1.16) Per Share, Cantor Fitzgerald Forecasts (MESO)
Mesoblast Limited (NASDAQ:MESO) – Equities researchers at Cantor Fitzgerald boosted their FY2018 EPS estimates for shares of Mesoblast Limited in a research report issued to clients and investors on Wednesday. Cantor Fitzgerald analyst E. Piros now anticipates that the company will earn ($1.16) per share for the year, up from their prior estimate of ($1.18). Cantor Fitzgerald has a “Buy” rating and a $20.00 price objective on the stock.
MESO has been the subject of several other reports. Zacks Investment Research downgraded Mesoblast Limited from a “buy” rating to a “sell” rating in a research note on Wednesday, May 17th. Credit Suisse Group set a $11.00 price target on Mesoblast Limited and gave the company a “hold” rating in a research note on Tuesday, July 18th. Maxim Group set a $14.00 price target on Mesoblast Limited and gave the company a “buy” rating in a research note on Wednesday. CIBC began coverage on Mesoblast Limited in a research note on Thursday. They issued an “outperform” rating and a $16.00 price target for the company. Finally, BidaskClub downgraded Mesoblast Limited from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $13.64.
Shares of Mesoblast Limited (NASDAQ MESO) traded up 1.35% on Friday, hitting $5.99. The company had a trading volume of 58,299 shares. The firm has a 50-day moving average price of $7.03 and a 200 day moving average price of $8.25. The company’s market capitalization is $508.46 million. Mesoblast Limited has a 12-month low of $4.01 and a 12-month high of $12.50.
An institutional investor recently raised its position in Mesoblast Limited stock. Princeton Capital Management Inc. increased its position in shares of Mesoblast Limited (NASDAQ:MESO) by 15.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 155,700 shares of the company’s stock after buying an additional 20,945 shares during the period. Princeton Capital Management Inc. owned approximately 0.20% of Mesoblast Limited worth $1,398,000 at the end of the most recent quarter. 2.95% of the stock is owned by hedge funds and other institutional investors.
About Mesoblast Limited
Receive News & Stock Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related stocks with our FREE daily email newsletter.